Proteon Therapeutics Inc (PRTO): Deerfield Management Discloses Post-IPO 6.7% Stake
James E.
Hedge Fund - Deerfield Management
News, Interviews, and Investor Letters
- First
- << Previous
- 81 - 90
- Next >>
Alimera Sciences Inc (ALIM) & Bio Blast Pharma Ltd (ORPN): 2 Pharmaceutical Stocks Hedge Funds are Increasing Their Stakes In
Pharmaceuticals and life sciences as a sector is where most of the money from hedge funds seems to be flowing in. However, it’s the sector-specific funds that are making the big purchases.
Entegris Inc (ENTG), Dicerna Pharmaceuticals Inc (DRNA): GMT Capital and Deerfield Management Report Their Latest Moves
In two new filings, Thomas E. Claugus' GMT Capital disclosed further raising its exposure to Entegris Inc (NASDAQ:ENTG).
Endologix, Inc. (ELGX): Deerfield Management Upping its Game
It seems the recent decline in Endologix, Inc. (NASDAQ:ELGX)’s stock by around 20% has made it more lucrative for hedge funds.
XenoPort, Inc. (XNPT) & CareDx Inc (CDNA): Two Life Sciences Stocks That Can Outperform
Julian Baker and Felix Baker’s Baker Bros. Advisors is tightening its grip over XenoPort, Inc. (NASDAQ:XNPT) and so is James E. Flynn’s Deerfield Management over CareDx Inc (NASDAQ:CDNA).
Visium Asset Management and Deerfield Management Are Bullish About These Stocks
Two Schedule 13G forms filed with the SEC yesterday called my attention.
AMAG Pharmaceuticals Inc. (AMAG): Deerfield Management Boosts Stake to Nearly 6%
Deerfield Management, managed by James E. Flynn, has disclosed upping its stake in AMAG Pharmaceuticals Inc. (NASDAQ:AMAG). A new filing with the U.S.
James E. Flynn's Deerfield Management Reveals Passive Stake in Amphastar Pharmaceuticals Inc. (AMPH)
James E. Flynn, the manager of Deerfield Management, has disclosed a new passive stake in Amphastar Pharmaceuticals Inc. (NASDAQ:AMPH). Mr.
Deerfield Management Discloses New Position in ANI Pharmaceuticals Inc (ANIP)
James E. Flynn's Deerfield Management reported a new stake in ANI Pharmaceuticals Inc (NASDAQ:ANIP).
Deerfield Ups Stake In Trivascular Technologies Inc (TRIV)
Deerfield Management, managed by James E. Flynn, has revealed raising its position in Trivascular Technologies Inc (NASDAQ:TRIV).
- First
- << Previous
- 81 - 90
- Next >>